Medicare Enrolled

Dr. Carl Kinzel, DO

Family Medicine · Battle Creek, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2545 CAPITAL AVE SW STE 201, Battle Creek, MI 49015
2692246190
In practice since 2008 (18 years)
NPI: 1992983209 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kinzel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kinzel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kinzel

Dr. Carl Kinzel is a family medicine specialist in Battle Creek, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kinzel performed 1,554 Medicare services across 795 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kinzel received a total of $10,600 from 52 pharmaceutical and/or device companies across 667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kinzel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 10% volume in MI $10,600 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,554
Medicare services
Top 10% in MI for family medicine
795
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
656 $80 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
363 $53 $142
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
161 $123 $245
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
142 $9 $20
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
72 $4 $4
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
55 $1 $14
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
41 $10 $18
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
32 $0 $11
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
21 $3 $4
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $95 $263
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,600
Total received (2018-2024)
Avg $1,514/year across 7 years
Top 3% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
667
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,254 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$345 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,362
2023
$2,192
2022
$2,372
2021
$1,331
2020
$1,020
2019
$802
2018
$521

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$348
Novo Nordisk Inc
$338
ABBVIE INC.
$264
GlaxoSmithKline, LLC.
$212
Amgen Inc.
$172
PFIZER INC.
$153
Janssen Pharmaceuticals, Inc
$142
Lilly USA, LLC
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$84
Bayer Healthcare Pharmaceuticals Inc.
$63
Daiichi Sankyo Inc.
$57
Exact Sciences Corporation
$52
Tolmar, Inc.
$48
Astellas Pharma US Inc
$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$43
Otsuka America Pharmaceutical, Inc.
$28
Insulet Corporation
$25
Inspire Medical Systems, Inc.
$24
Dexcom, Inc.
$23
Lundbeck LLC
$23
Teva Pharmaceuticals USA, Inc.
$23
Tempus AI, Inc
$21
Collegium Pharmaceutical, Inc.
$19
AIMMUNE THERAPEUTICS, INC.
$15
Top 3 companies account for 40.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,206
Amgen Inc.
$1,354
Lilly USA, LLC
$855
GlaxoSmithKline, LLC.
$738
PFIZER INC.
$676
ABBVIE INC.
$656
AstraZeneca Pharmaceuticals LP
$638
Astellas Pharma US Inc
$452
Janssen Pharmaceuticals, Inc
$355
Bayer Healthcare Pharmaceuticals Inc.
$213
Dexcom, Inc.
$202
Boehringer Ingelheim Pharmaceuticals, Inc.
$198
Biohaven Pharmaceutical Holding Company Ltd.
$156
Ironshore Pharmaceuticals Inc.
$140
Daiichi Sankyo Inc.
$130
Abbott Laboratories
$124
Teva Pharmaceuticals USA, Inc.
$117
Exact Sciences Corporation
$113
Bayer HealthCare Pharmaceuticals Inc.
$111
Otsuka America Pharmaceutical, Inc.
$90
Novartis Pharmaceuticals Corporation
$89
GRT US Holding, Inc.
$82
Nestle HealthCare Nutrition Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$59
AbbVie, Inc.
$59
IBSA Pharma Inc.
$58
Avanir Pharmaceuticals, Inc.
$56
Tolmar, Inc.
$48
Nevro Corp.
$45
Actelion Pharmaceuticals US, Inc.
$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$43
Horizon Therapeutics plc
$38
AbbVie Inc.
$29
Averitas Pharma Inc.
$29
Insulet Corporation
$25
Inspire Medical Systems, Inc.
$24
Orexo US, Inc.
$23
Lundbeck LLC
$23
Tempus AI, Inc
$21
MannKind Corporation
$21
Collegium Pharmaceutical, Inc.
$19
Indivior Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
AIMMUNE THERAPEUTICS, INC.
$15
SANOFI-AVENTIS U.S. LLC
$15
Amarin Pharma Inc.
$15
Neurocrine Biosciences, Inc.
$14
ITI, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$13
SANOFI PASTEUR INC.
$13
Medline Industries, Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AIRSUPRA · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · Austedo XR · BREZTRI · Belbuca · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · Creon · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FLECTOR · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · Humira · INJECTAFER · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Kerendia · LINZESS · LYRICA · Licart · MENACTRA · MOTEGRITY · MOUNJARO · MYRBETRIQ · Myrbetriq · NUEDEXTA · NURTEC ODT · Nuedexta · OFEV · ONGENTYS · OPSUMIT · ORIAHNN · Omnia · Omnipod · Orilissa · Otezla · Ozempic · PENNSAID · PREVNAR - 13 · PREVNAR 13 · Prolia · QULIPTA · QUTENZA · Qutenza · RELISTOR · REXULTI · REYVOW · RINVOQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPRAVATO · SUBLOCADE · SYMBICORT · Saxenda · Senza · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · UBRELVY · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZENPEP · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in MI.

Looking for a family medicine specialist in Battle Creek?
Compare family medicine physicians in the Battle Creek area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
221
Per 100K population
165.1
County median income
$60,385
Nearest hospital
BRONSON BEHAVIORAL HEALTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kinzel is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with low-engagement industry engagement in the top 3% of MI peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kinzel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kinzel performed 656 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kinzel receive payments from pharmaceutical companies?
Yes. Dr. Kinzel received a total of $10,600 from 52 companies across 667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kinzel's costs compare to other family medicine physicians in Battle Creek?
Dr. Kinzel's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kinzel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →